Publications
65
Citations
107
Est. group size
—
Recurring co-author estimate
Active years
8
Publishing since 2019
Amy C. Ogilvie's research focuses on health services and outcomes for people living with Huntington's disease, examining topics such as diagnosis timing, health care utilization, place of death, hospice access, and racial and geographic disparities in care. She also studies disparities in breast cancer diagnosis and treatment using large administrative datasets like SEER-Medicare. This work is aimed at understanding how patient outcomes and access to care vary across populations and over the course of chronic and progressive illnesses.
Publication output was minimal before 2022 but grew sharply starting in 2023, followed by somewhat lower but still active output through 2025-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Additional file 1 of Higher educational attainment in Huntington disease families: evidence from the Enroll-HD study
Figshare · 2026
- Additional file 1 of Higher educational attainment in Huntington disease families: evidence from the Enroll-HD study
Figshare · 2026
- Higher educational attainment in Huntington disease families: evidence from the Enroll-HD study
UNC Libraries · 2026
- Predictors of Health Care Utilization for Individuals With Manifest Huntington Disease
Neurology Clinical Practice · 2025
- Disparities in Access and Outcomes for Hospitalized California Patients with Huntington’s Disease (HD) (P4-5.019)
Neurology · 2025
- Supplementary Table 4 from Patterns of Evidence-Based Care for the Diagnosis, Staging, and First-line Treatment of Breast Cancer by Race–Ethnicity: A SEER-Medicare Study
2025
- Supplementary Table 1 from Patterns of Evidence-Based Care for the Diagnosis, Staging, and First-line Treatment of Breast Cancer by Race–Ethnicity: A SEER-Medicare Study
2025
- Supplementary Table 2 from Patterns of Evidence-Based Care for the Diagnosis, Staging, and First-line Treatment of Breast Cancer by Race–Ethnicity: A SEER-Medicare Study
2025
- Supplementary Figure 1 from Patterns of Evidence-Based Care for the Diagnosis, Staging, and First-line Treatment of Breast Cancer by Race–Ethnicity: A SEER-Medicare Study
2025
- Supplementary Table 3 from Patterns of Evidence-Based Care for the Diagnosis, Staging, and First-line Treatment of Breast Cancer by Race–Ethnicity: A SEER-Medicare Study
2025
- Increases in Advance Directive Completion Through the Patient Portal Among Younger and Healthier Population During the COVID-19 Pandemic
Journal of Palliative Medicine · 2025
- β-Blocker Use and Delayed Onset and Progression of Huntington Disease
JAMA Neurology · 2024
- Exploring Place of Death among Individuals with Huntington's Disease in the United States
Journal of the American Medical Directors Association · 2024
- Racial Disparities in Time to Huntington Disease Diagnosis in North America
Neurology Clinical Practice · 2024
- Factors Influencing Discharges to Hospice for Patients With Late-Stage Huntington’s Disease
American Journal of Hospice and Palliative Medicine® · 2024
- American Journal of Hospice and Palliative Medicine®×3
- Parkinsonism & Related Disorders×2
- Neurology Clinical Practice×2
- Movement Disorders×2
- Neurology×2
- Demond Handley
Medicine · The Ohio State University
- Samilia Obeng‐Gyasi
Medicine · The Ohio State University
- JC Chen
Medicine · The Ohio State University
- Oindrila Bhattacharyya
Medicine · The Ohio State University
- Electra D. Paskett
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile